Any prospect of a take over at this low price, page-2

Spending cash a necessary evil mate, especially for start ups, the relevant concern is how soon can Admedus receive a ROI for this expenditure.

Seriously doubt there will be any CR in the foreseeable future, funding thru debt worst case scenario.

If value of Admedus IP TRULY superior/cutting edge/break thru and has the potential to grab significant market share, then maybe interest from a big player.

Above scenario (superior/cutting edge tech) would be a 'gold mine' for the 'big player' who has the resources/time to bring these products to commercial success, as WP has stated, superior IP does not guarantee success.

If sp continues to languish, even drop below 20 cents, (true b.......y nightmare) this is not a ideal outcome for investors, imo, in regards to receiving any decent premium as a t/o target.

Heck of a lot riding on the ROI these next two quarterlies!

Ps: Sure Admedus will be still here in the short term, perhaps not in its present form in the medium/long term future.